Literature DB >> 22611237

A p53 axis regulates B cell receptor-triggered, innate immune system-driven B cell clonal expansion.

Hyunjoo Lee1, Shabirul Haque, Jennifer Nieto, Joshua Trott, John K Inman, Steven McCormick, Nicholas Chiorazzi, Patricia K A Mongini.   

Abstract

Resting mature human B cells undergo a dynamic process of clonal expansion, followed by clonal contraction, during an in vitro response to surrogate C3d-coated Ag and innate immune system cytokines, IL-4 and BAFF. In this study, we explore the mechanism for clonal contraction through following the time- and division-influenced expression of several pro- and anti-apoptotic proteins within CFSE-labeled cultures. Several findings, involving both human and mouse B cells, show that a mitochondria-dependent apoptotic pathway involving p53 contributes to the high activation-induced cell death (AICD) susceptibility of replicating blasts. Activated B cell clones exhibit elevated p53 protein and elevated mRNA/protein of proapoptotic molecules known to be under direct p53 transcriptional control, Bax, Bad, Puma, Bid, and procaspase 6, accompanied by reduced anti-apoptotic Bcl-2. Under these conditions, Bim levels were not increased. The finding that full-length Bid protein significantly declines in AICD-susceptible replicating blasts, whereas Bid mRNA does not, suggests that Bid is actively cleaved to short-lived, proapoptotic truncated Bid. AICD was diminished, albeit not eliminated, by p53 small interfering RNA transfection, genetic deletion of p53, or Bcl-2 overexpression. DNA damage is a likely trigger for p53-dependent AICD because susceptible lymphoblasts expressed significantly elevated levels of both phosphorylated ataxia telangiectasia mutated-Ser(1980) and phospho-H2AX-Ser(139). Deficiency in activation-induced cytosine deaminase diminishes but does not ablate murine B cell AICD, indicating that activation-induced cytosine deaminase-induced DNA damage is only in part responsible. Evidence for p53-influenced AICD during this route of T cell-independent clonal expansion raises the possibility that progeny bearing p53 mutations might undergo positive selection in peripherally inflamed tissues with elevated levels of IL-4 and BAFF.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22611237      PMCID: PMC3370112          DOI: 10.4049/jimmunol.1103037

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  127 in total

Review 1.  The guardians of the genome (p53, TA-p73, and TA-p63) are regulators of tumor suppressor miRNAs network.

Authors:  Lakshmanane Boominathan
Journal:  Cancer Metastasis Rev       Date:  2010-12       Impact factor: 9.264

2.  Wild-type p53 transactivates the KILLER/DR5 gene through an intronic sequence-specific DNA-binding site.

Authors:  R Takimoto; W S El-Deiry
Journal:  Oncogene       Date:  2000-03-30       Impact factor: 9.867

3.  Ubiquitin-mediated degradation of the proapoptotic active form of bid. A functional consequence on apoptosis induction.

Authors:  K Breitschopf; A M Zeiher; S Dimmeler
Journal:  J Biol Chem       Date:  2000-07-14       Impact factor: 5.157

4.  B lymphocyte stimulator activates p38 mitogen-activated protein kinase in human Ig class switch recombination.

Authors:  Takechiyo Yamada; Ke Zhang; Akiko Yamada; Daocheng Zhu; Andrew Saxon
Journal:  Am J Respir Cell Mol Biol       Date:  2005-01-24       Impact factor: 6.914

5.  Role of genomic instability and p53 in AID-induced c-myc-Igh translocations.

Authors:  Almudena R Ramiro; Mila Jankovic; Elsa Callen; Simone Difilippantonio; Hua-Tang Chen; Kevin M McBride; Thomas R Eisenreich; Junjie Chen; Ross A Dickins; Scott W Lowe; Andre Nussenzweig; Michel C Nussenzweig
Journal:  Nature       Date:  2006-01-08       Impact factor: 49.962

6.  Association between circulating levels of the novel TNF family members APRIL and BAFF and lymphoid organization in primary Sjögren's syndrome.

Authors:  Malin V Jonsson; Peter Szodoray; Stig Jellestad; Roland Jonsson; Kathrine Skarstein
Journal:  J Clin Immunol       Date:  2005-05       Impact factor: 8.317

7.  Respiratory tract infections and subsequent risk of chronic lymphocytic leukemia.

Authors:  Ola Landgren; Joshua S Rapkin; Neil E Caporaso; Lene Mellemkjaer; Gloria Gridley; Lynn R Goldin; Eric A Engels
Journal:  Blood       Date:  2006-11-02       Impact factor: 22.113

8.  The BCL6 proto-oncogene suppresses p53 expression in germinal-centre B cells.

Authors:  Ryan T Phan; Riccardo Dalla-Favera
Journal:  Nature       Date:  2004-12-02       Impact factor: 49.962

9.  Development and maintenance of B and T lymphocytes requires antiapoptotic MCL-1.

Authors:  Joseph T Opferman; Anthony Letai; Caroline Beard; Mia D Sorcinelli; Christy C Ong; Stanley J Korsmeyer
Journal:  Nature       Date:  2003-12-11       Impact factor: 49.962

10.  The E3 ubiquitin ligase Mule acts through the ATM-p53 axis to maintain B lymphocyte homeostasis.

Authors:  Zhenyue Hao; Gordon S Duncan; Yu-Wen Su; Wanda Y Li; Jennifer Silvester; Claire Hong; Han You; Dirk Brenner; Chiara Gorrini; Jillian Haight; Andrew Wakeham; Annick You-Ten; Susan McCracken; Andrew Elia; Qinxi Li; Jacqui Detmar; Andrea Jurisicova; Elias Hobeika; Michael Reth; Yi Sheng; Philipp A Lang; Pamela S Ohashi; Qing Zhong; Xiaodong Wang; Tak W Mak
Journal:  J Exp Med       Date:  2012-01-02       Impact factor: 14.307

View more
  6 in total

1.  Mechanistic Insights into CpG DNA and IL-15 Synergy in Promoting B Cell Chronic Lymphocytic Leukemia Clonal Expansion.

Authors:  Rashmi Gupta; Xiao J Yan; Jacqueline Barrientos; Jonathan E Kolitz; Steven L Allen; Kanti Rai; Nicholas Chiorazzi; Patricia K A Mongini
Journal:  J Immunol       Date:  2018-08-01       Impact factor: 5.422

2.  TLR-9 and IL-15 Synergy Promotes the In Vitro Clonal Expansion of Chronic Lymphocytic Leukemia B Cells.

Authors:  Patricia K A Mongini; Rashmi Gupta; Erin Boyle; Jennifer Nieto; Hyunjoo Lee; Joanna Stein; Jela Bandovic; Tatjana Stankovic; Jacqueline Barrientos; Jonathan E Kolitz; Steven L Allen; Kanti Rai; Charles C Chu; Nicholas Chiorazzi
Journal:  J Immunol       Date:  2015-07-01       Impact factor: 5.422

3.  Mechanism for IL-15-Driven B Cell Chronic Lymphocytic Leukemia Cycling: Roles for AKT and STAT5 in Modulating Cyclin D2 and DNA Damage Response Proteins.

Authors:  Rashmi Gupta; Wentian Li; Xiao J Yan; Jacqueline Barrientos; Jonathan E Kolitz; Steven L Allen; Kanti Rai; Nicholas Chiorazzi; Patricia K A Mongini
Journal:  J Immunol       Date:  2019-04-15       Impact factor: 5.422

4.  Effects of prostaglandin E2 on p53 mRNA transcription and p53 mutagenesis during T-cell-independent human B-cell clonal expansion.

Authors:  Shabirul Haque; Xiao Jie Yan; Lisa Rosen; Steven McCormick; Nicholas Chiorazzi; Patricia K A Mongini
Journal:  FASEB J       Date:  2013-10-21       Impact factor: 5.191

5.  The Role of Aggregates of Therapeutic Protein Products in Immunogenicity: An Evaluation by Mathematical Modeling.

Authors:  Liusong Yin; Xiaoying Chen; Abhinav Tiwari; Paolo Vicini; Timothy P Hickling
Journal:  J Immunol Res       Date:  2015-11-22       Impact factor: 4.818

Review 6.  Cooperation of Oligodeoxynucleotides and Synthetic Molecules as Enhanced Immune Modulators.

Authors:  Shireen Nigar; Takeshi Shimosato
Journal:  Front Nutr       Date:  2019-08-27
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.